About Sophie Zettl

This author has not yet filled in any details.
So far Sophie Zettl has created 2 blog entries.

YGION Biomedical at Partnering Conferences

2024-09-25T09:39:03+02:00September 24, 2024|News|

The YGION Biomedical team will be attending a number of international conferences this Autumn. To explore partnerships in Asia and beyond, the team will be joining the Austrian delegation of the EU-Japan Biotech & Pharma Partnering Conference on 7-9th October 2024 in Osaka, Japan, followed by BioJapan 2024 in Yokohama, Japan. On October 10-11th 2024, the team will join key players from the Austrian and international biotech industry at the 2nd Biotech Summit Austria in Innsbruck, Austria. On November 4-6th 2024, the team will attend Europe's premier partnering event, BioEurope 2024 in Stockholm, Sweden. These international conferences connect delegates spanning the global life science ecosystem to propel dealmaking and innovation. BioJapan 2024 Biotech Austria Summit BioEurope 2024 … read more

YGION Biomedical Awarded Grant from the Austrian Research Promotion Agency to develop Individualized Cancer Immunotherapies

2024-06-22T13:15:54+02:00June 18, 2024|News|

YGION Biomedical GmbH, a company dedicated to developing individualized neoantigen-based cancer immunotherapies, today announces further fundraising news with the award of a significant Life Sciences grant from the Austrian Research Promotion Agency (Forschungsförderungsgesellschaft; FFG). This non-dilutive funding will be used over the next 12 months to further development YGION’s unique YGNITE™ technology platform and support preclinical development of YGION’s lead program, YG1. YGION is committed to developing individualized “plug-and-play” cancer vaccines using a proprietary suite of technologies to identify, produce and target the delivery of relevant peptide neoantigens resulting in safe, exceptionally potent, and precise targeted activation of the patient’s immune system. “With this support from the FFG, we will take an important step forward … read more

Go to Top